In a scientific first, researchers have turned plastic waste into a mainstay treatment for Parkinson’s disease (PD). In a proof-of-concept study, researchers used engineered bacteria to convert ...

In the vast majority of cases of Parkinson’s disease, or “shaking palsy,” physicians cannot be sure what originally caused the nerve damage that results in the patient’s tremor, muscle rigidity, ...

A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD). Led by 2014 BBRF ...

Though the drug levodopa can dramatically improve Parkinson's disease symptoms, within five years one-half of the patients using L-DOPA develop an irreversible condition -- involuntary repetitive, ...

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown. A side effect that then ...

Researchers at the University of Edinburgh are working on engineering bacteria to convert chemicals derived from waste plastic bottles into L-DOPA, a key drug used to treat Parkinson’s disease. The ...

The U.S. Food and Drug Administration has given approval for the drug Stalevo-a cocktail of levodopa (L-dopa), carbidopa, and entacapone-to be marketed in the United States for the treatment of ...

A drug used to treat Parkinson's disease could also help people with phobias or post-traumatic stress disorder (PTSD). Scientists of the Translational Neurosciences (FTN) Research Center at Johannes ...

The report entitled "Modification of Parkinsonism—Chronic treatment with L-dopa," by Cotzias, Papavasiliou and Gellene in this issue, is the second publication of their work in the Journal 1 and ...